A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
Novo Nordisk board members step down after major shareholder dispute
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Stock market today: Live updates
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October…
Novo Nordisk and Omeros announce asset purchase and license
Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease…
Stock market news for Oct. 9, 2025
A trader works at the New York Stock Exchange on Oct. 3, 2025. NYSE The S&P 500 and…
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of…
Pfizer’s new obesity bet, Metsera, releases drug data
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
Wegovy-maker Novo Nordisk to cut around 9,000 jobs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…
Novo Nordisk’s Martin Holst Lange previews obesity pill
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Eli Lilly’s Daniel Skovronsky talks obesity pill data
The Eli Lilly headquarters in Indianapolis, Indiana, on Aug. 15, 2024. AJ Mast | Bloomberg | Getty Images…
Novo Nordisk offers diabetes drug Ozempic for steep cash discount
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie…